Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Oct;65(2):211-4.
doi: 10.1007/BF00433051.

Characterization of 3H-GABA receptor binding to rat brain synaptosomal membranes: effect of non GABAergic compounds

Characterization of 3H-GABA receptor binding to rat brain synaptosomal membranes: effect of non GABAergic compounds

J Hyttel. Psychopharmacology (Berl). 1979 Oct.

Abstract

Characteristics of 3H-GABA binding to rat brain synaptic membranes in vitro have been investigated. The specific binding of 3H-GABA displays saturation kinetics. Only one single population of receptor sites was found (Km = 31.3 nM) with a concentration of 2.09 pmol/mg protein. Only GABA agonists show inhibitory effect on the binding, whereas GABA antagonists, GABA-uptake inhibitors, and inhibitors of GAD and GABA-T are without effect. The order of potencies for GABA agonists are: Muscimol greater than GABA greater than or equal to 4,5-dihydromuscimol greater than 3-aminoproprane sulphonic acid greater than isoguvacine greater than THIP greater than 3-hydroxy-GABA greater than imidazol-4-acetic acid. Agonists and antagonists from other neurone systems as well as neuroleptics and benzodiazepines had no or only a very slight potency in the binding test.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1974 Dec;71(12):4802-7 - PubMed
    1. J Pharm Pharmacol. 1978 Dec;30(12):771-8 - PubMed
    1. Brain Res. 1978 Jun 9;148(1):153-62 - PubMed
    1. Neuropharmacology. 1977 May;16(5):333-42 - PubMed
    1. J Pharm Pharmacol. 1978 Jan;30(1):46-8 - PubMed

Substances

LinkOut - more resources